secwatch.observer — SEC 8-K summary
======================================

Issuer:     ASHLAND INC. (ASH)
CIK:        0001674862
Form:       8-K
Filed at:   2023-11-14T23:59:59+00:00
Accession:  0000950170-23-063863
Event type: leadership
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ashland appoints Merck EVP Sanat Chattopadhyay to board; two directors not seeking re-election
--------------------------------------------------------------------------------

- Sanat Chattopadhyay, executive vice president of Merck (MRK), joined Ashland board effective Nov. 13, 2023.
- Chattopadhyay serves on Environmental, Health, Safety, and Quality and Governance and Nominating Committees.
- Directors Jay V. Ihlenfeld and Brendan M. Cummins will not stand for re-election at January 2024 annual meeting.
- Board temporarily expands to 11 members until the 2024 annual meeting.
- Chattopadhyay brings experience in biopharma operations, manufacturing, and global supply chain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1674862/000095017023063863/0000950170-23-063863-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1674862/000095017023063863/ash-20231113.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-063863

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer